Shukra Pharmaceuticals Ltd Share Price

Pharmaceuticals

BSE: 524632 Small Cap ISIN: INE551C01044

As on 18 November 2025 at 23:47 IST

Stock Not Traded in BSE

Over 1 Month

19.02%

Over 6 Months

202.25%

Over 1 Year

606.70%

Over 3 Years

5238.55%

Shukra Pharmaceuticals Ltd Summary

Close ₹44.31

Open ₹44.31

High ₹44.31

Low ₹44.31

Volume 3,73,656

Net Turnover (in Cr) ₹1.66

52Wk High ₹44.31

52Wk Low ₹5.75

52Wk High / Low

5.75

44.31

Shukra Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹1,940.24

EPS (TTM) 0.27

Book Value (BV) 1.50

Div. Yield 0.02 %

P/E (TTM) 164.11

Price/Book Value 29.48

Delivery % 100 %

Face Value 1

Key Ratios

PE Ratio 99.32

PB Ratio 15.17

EV to Sales 29.11

PEG Ratio -1.01

ROA 14.27

ROE 15.90

Debt-Equity 0.06

Net Profit Margin 29.40

Operating Profit Margin 51.95

Shukra Pharmaceuticals Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	36.79	77.39	60.03	20.57	11.55
Total Expenses	23.46	57.50	55.59	19.55	11.26
Profit Before Tax	13.34	19.88	4.44	1.02	0.10
Profit After Tax	9.58	18.54	4.41	0.75	0.19
Operating Profit After Depreciation	13.93	20.17	4.72	1.30	0.33

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	19.40	19.94	20.23	17.58	17.69
Total Non Current Assets	21.34	21.60	21.89	19.24	19.55
Total Current Assets	65.43	56.23	53.07	15.87	16.06
Total Assets	86.77	77.84	74.97	35.11	35.61
Total Shareholder's Fund	62.84	57.64	25.30	16.35	15.60

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	7.92	-5.20	3.17	7.99	0.54
Net Cash Used In Investing Activities	-1.26	-1.20	-4.43	-1.53	-1.89
Net Cash Used In Financing Activities	-4.52	12.41	4.94	-6.68	1.74

No data available

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	5.88	5.39	13.27	10.58	5.56
Total Expenses	6.30	4.07	5.95	6.64	4.89
Profit Before Tax	0.19	1.37	7.58	4.10	0.88
Profit After Tax	2.38	1.03	5.39	3.16	0.54
Operating Profit after Depreciation	1.29	2.43	8.79	4.95	1.69

Shukra Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 44.31

S2 44.31

S3 44.31

Pivot 44.31

R1 44.31

R2 44.31

R3 44.31

Moving Average

20 SMA 40.81

50 SMA 35.48

100 SMA 27.74

200 SMA 23.21

Shukra Pharmaceuticals Ltd Corporate Actions

Shukra Pharmaceuticals Ltd

₹0.01/Share

Announcement Date 18 Sep 2025

Record Date 18 Sep 2025

Div Yield 1%

AGM Date: 30 Dec 2020

The Company is hereby submit the outcome of The Board Meeting. This is with reference to the above mentioned subject and in terms of applicable regulations of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we are enclosing herewith a copy of notice of Annual General Meeting of the Company scheduled to be held on Wednesday, 30th December, 2020 at 11.00 A.M. at the registered office of the Company and also through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM'). Kindly take the same on your records and acknowledge the receipt thereof. Site (As per BSE Announcement Dated on 24/12/2020) Proceedings of Annual General Meeting held on 30th December, 2020. (As per BSE Announcement Dated on 30/12/2020) With reference to above, please find copy of Annual Report for Financial Year 2019-2020 in compliance in with Regulation 34 of SEBI (Listing obligation and Disclosure Requirement) Regulations, 2015. (As Per BSE Announcement Dated on 26/01/2021)

AGM Date: 30 Sep 2021

Proceeding of AGM for the FY 2020-21 Proceeding of AGM for the FY 2020-21 (As Per BSE announcement Dated on 30.09.2021) Voting Result(As Per BSE Announcement Dated on 10/2/2021 3:22:02 AM) Scrutinizer Report of AGM for FY 2020-21(As Per BSE Announcement Dated on 10/2/2021 3:25:35 AM)

AGM Date: 30 Sep 2021

Proceeding of AGM for the FY 2020-21 Voting Result(As Per BSE Announcement Dated on 10/2/2021 3:22:02 AM) Scrutinizer Report of AGM for FY 2020-21(As Per BSE Announcement Dated on 10/2/2021 3:25:35 AM)

AGM Date: 29 Sep 2022

AGM 29/09/2022 1) Approval and adoption of Director's Report and Secretarial Audit Report for the year ended March 31, 2022. 2) Annual General Meeting of the company will be held on Thursday, 29th day of September, 2022 at registered office of the company. 3) Register of Members & Share Transfer Books of the Company will remain close from 23rd September, 2022 to 29th September, 2022 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the company. 4) Approval of draft notice for Annual General Meeting. 5) Appointment of Mrs. Rupal Patel, Practicing Company Secretary as Scrutinizer for the process of Remote E-voting as well as voting at the AGM. 6) Appointment of Shailesh Patel as an internal auditor of the company for the FY 2022-23. 7) Reviewed the businesses of the company. (As Per BSE Announcement dated on 02.09.2022) Intimation Of Record Date For The Purpose Of Dividend For The Financial Year 2021-22. (As Per BSE Announcement Dated on 10.09.2022) We wish to inform you that Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we enclose herewith copy of notice published in Newspaper on 13th September, 2022 regarding Annual General Meeting, Book Closure and instruction for e-voting. (As Per BSE Announcement dated on 14.09.2022) Summary of Proceeding of Annual General Meeting of the Company Held on 29th September 2022 at 03.00 p.m. Summary of Proceeding of Annual General Meeting of the Company Held on 29th September 2022 at 03.00 p.m. (As Per BSE Announcement Dated on 29/09/2022)

AGM Date: 22 Sep 2023

Board Meeting Outcome for Meeting Of Board Of Directors Held On August 16, 2023 Convening the 3Oth Annual General Meeting ('AGM') of the shareholders of thc Contpany at 11,30 a,m,, on Friday, September 22, 2023 at the registered re company florseeking their approval and approved the draft Notice of AGM Proceeding of 30th Annual General Meeting of the company held on September 22, 2023 at 11.30 a.m. at the Registered Office of the Company. (As Per BSE Announcement dated on 22.09.2023) Submission of Voting Result along with Scrutiniser Report for the 30th Annual General Meeting held on Spetember 22, 2023 at the registered office of the company. Submission of Voting Result along with Scrutiniser report of the 30th Annual General Meeting (As per BSE Announcement Dated on 23/09/2023)

AGM Date: 30 Sep 2024

Please Find Attach Notice for convening the 31st AGM of the company at the registered office of the company AGM at the registered office of the company (As Per BSE Announcement dated on 03.10.2024)

AGM Date: 30 Sep 2025

Register of Members & Share Transfer Books of the Company will remain close from September 23, 2025 to September 29, 2025 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the company. Revision in date of AGM (As per BSE Announcement Dated on 08.09.2025) Newspaper Advertisement Of Notice Of 32nd Annual General Meeting[AGM] (As Per BSE Announcement Dated on 10.09.2025) Proceeding of the company. (As Per BSE Announcement Dated on:30.09.2025) As attached. Voting Result Along With Scrutinizer Report Of 32Nd Annual General Meeting ('AGM') Of The Company Held On September 30, 2025. (As per BSE Announcement dated on: 03.10.2025)

Shukra Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,763.70	₹4,23,170.71
Divis Laboratories Ltd	₹6,523.25	₹1,73,171.79
Torrent Pharmaceuticals Ltd	₹3,816.75	₹1,29,170.36
Cipla Ltd	₹1,536.25	₹1,24,093.85
Dr Reddys Laboratories Ltd	₹1,244.50	₹1,03,868.61

Shukra Pharmaceuticals Ltd Top Mutal Funds Invested

No data available

Shukra Pharmaceuticals Ltd News

Shukra Pharmaceuticals to declare Quarterly Results

On 13 November 2025

01 Nov 2025, 11:01 am

Shukra Pharmaceuticals schedules EGM

On 1 November 2025

06 Oct 2025, 10:02 am

Shukra Pharmaceuticals to discuss results

On 3 October 2025

23 Sep 2025, 09:48 am

Shukra Pharmaceuticals to hold AGM

On 30 September 2025

16 Sep 2025, 10:54 am

Shukra Pharmaceuticals schedules AGM

On 29 September 2025

05 Sep 2025, 02:25 pm

Shukra Pharmaceuticals Ltd Stock Analysis

Annual revenue for Shukra Pharmaceuticals Ltd decreased by 52.46% to ₹36.79 crore in FY 2025 from ₹77.39 crore in FY 2024.
Annual Net Profit for Shukra Pharmaceuticals Ltd decreased by 48.35% to ₹9.58 crore in FY 2025 from ₹18.54 crore in FY 2024.
Promoter Shareholding in Shukra Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 50.96% in June 2025 to 50.96% in September 2025.
Shukra Pharmaceuticals Ltd delivered a 1-year return of 606.70% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Shukra Pharmaceuticals Ltd share price moved down by 100.00% from its previous close of INR ₹44.31. The latest Shukra Pharmaceuticals Ltd share price is INR ₹0.
Shukra Pharmaceuticals Ltd share price today has been at a low of 43.43 and a high of 43.43. Over the past 52 weeks, the Shukra Pharmaceuticals Ltd share price has seen a low of 5.75 and a high of 44.31.